MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy.

Autor: Esfandyari YB; Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran.; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Doustvandi MA; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Amini M; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Zaer SJ; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Mozammel N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Mohammadzadeh M; Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran. m.mohamadzade@urmia.ac.ir., Mokhtarzadeh A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. mokhtarzadehah@tbzmed.ac.ir.

Publikováno v: Reproductive sciences (Thousand Oaks, Calif.) [Reprod Sci] 2021 Jul; Vol. 28 (7), pp. 2036-2049. Date of Electronic Publication: 2021 Feb 10.